Svb Leerink Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Svb Leerink
Rating: 2.4
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Svb Leerink. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Svb Leerink.

Date	Brokerage	Action	Company	Rating	Price Target	Impact on Price
12/6/2019	Svb Leerink	Upgrades	SAGE Therapeutics (SAGE)	Underperform -> Market Perform		High
12/2/2019	Svb Leerink	Reiterates	Centogene (CNTG)	Outperform		High
12/4/2019	Svb Leerink	Reiterates	Audentes Therapeutics (BOLD)	Outperform -> Market Perform		Low
12/2/2019	Svb Leerink	Initiates	GlaxoSmithKline (GSK)	Outperform		Low
11/26/2019	Svb Leerink	Downgrades	CymaBay Therapeutics (CBAY)	Outperform -> Market Perform		High
11/26/2019	Svb Leerink	Downgrades	The Medicines (MDCO)	Outperform -> Market Perform	$78.00 -> $85.00	Low
11/26/2019	Svb Leerink	Initiates	Evolus (EOLS)	Outperform	$25.00	Medium
11/26/2019	Svb Leerink	Upgrades	bluebird bio (BLUE)	Market Perform -> Outperform	$119.00	Low
11/22/2019	Svb Leerink	Initiates	AstraZeneca (AZN)	Outperform		Low
11/19/2019	Svb Leerink	Initiates	Progyny (PGNY)	Outperform	$28.00	High

11/18/2019	Svb Leerink	Downgrades	Wright Medical Group (WMGI)	Outperform -> Market Perform		Low
11/15/2019	Svb Leerink	Downgrades	resTORbio (TORC)	Outperform -> Market Perform		High
11/15/2019	Svb Leerink	Raises Target	Amarin (AMRN)	Outperform	$26.00 -> $29.00	High
11/15/2019	Svb Leerink	Initiates	Genocea Biosciences (GNCA)	Outperform	$7.00	High
11/12/2019	Svb Leerink	Reiterates	Heron Therapeutics (HRTX)	Outperform		Medium
11/11/2019	Svb Leerink	Reiterates	Innate Pharma (IPHA)	Outperform		Medium
11/7/2019	Svb Leerink	Downgrades	Amneal Pharmaceuticals (AMRX)	Outperform -> Market Perform		High
11/4/2019	Svb Leerink	Initiates	BioNTech (BNTX)	Outperform		High
10/29/2019	Svb Leerink	Upgrades	Deciphera Pharmaceuticals (DCPH)	Underperform -> Market Perform	$29.00 -> $34.00	Medium
10/23/2019	Svb Leerink	Upgrades	Biogen (BIIB)	Market Perform -> Outperform	$256.00 -> $350.00	High
10/22/2019	Svb Leerink	Upgrades	Aclaris Therapeutics (ACRS)	Market Perform -> Outperform		High
10/18/2019	Svb Leerink	Downgrades	Achillion Pharmaceuticals (ACHN)	Outperform -> Market Perform	$5.00 -> $6.30	Medium
10/15/2019	Svb Leerink	Reiterates	Repligen (RGEN)	Outperform	$100.00	High
10/10/2019	Svb Leerink	Reiterates	Mereo BioPharma Group (MREO)	Outperform		High
10/11/2019	Svb Leerink	Downgrades	Ra Pharmaceuticals (RARX)	Outperform -> Market Perform	$38.00 -> $48.00	High
10/8/2019	Svb Leerink	Initiates	Satsuma Pharmaceuticals (STSA)	Outperform		High
10/2/2019	Svb Leerink	Reiterates	Seattle Genetics (SGEN)	Outperform		Low
9/24/2019	Svb Leerink	Raises Target	Insulet (PODD)	Outperform	$160.00 -> $185.00	High
9/24/2019	Svb Leerink	Raises Target	Ardelyx (ARDX)	Outperform	$8.00 -> $9.00	High
9/24/2019	Svb Leerink	Downgrades	Clovis Oncology (CLVS)	Outperform -> Market Perform	$22.00 -> $10.00	High
9/16/2019	Svb Leerink	Downgrades	Alder Biopharmaceuticals (ALDR)	Outperform -> Market Perform		Low
9/17/2019	Svb Leerink	Initiates	Axonics Modulation Technologies (AXNX)	Outperform	$45.00	High
9/13/2019	Svb Leerink	Upgrades	ACADIA Pharmaceuticals (ACAD)	Market Perform -> Outperform	$21.00 -> $50.00	Low
9/12/2019	Svb Leerink	Raises Target	T2 Biosystems (TTOO)	Outperform	$3.00 -> $5.00	Medium
9/4/2019	Svb Leerink	Raises Target	Teleflex (TFX)	Outperform	$395.00 -> $405.00	Medium
8/20/2019	Svb Leerink	Upgrades	Regenxbio (RGNX)	Underperform -> Market Perform	$38.00 -> $37.00	High
8/19/2019	Svb Leerink	Initiates	Myovant Sciences (MYOV)	Outperform	$26.00	High
8/19/2019	Svb Leerink	Upgrades	Solid Biosciences (SLDB)	Market Perform -> Outperform	$8.00 -> $15.00	High
8/19/2019	Svb Leerink	Initiates	Livongo Health (LVGO)	Outperform	$50.00	High
8/19/2019	Svb Leerink	Initiates	Health Catalyst (HCAT)	Outperform	$55.00	Medium
8/19/2019	Svb Leerink	Initiates	Castle Biosciences (CSTL)	Outperform	$28.00	High
8/16/2019	Svb Leerink	Initiates	Merck & Co., Inc. (MRK)	Outperform -> Outperform	$103.00	Low
8/12/2019	Svb Leerink	Reiterates	Fulcrum Therapeutics (FULC)	Outperform		High
8/14/2019	Svb Leerink	Initiates	Amarin (AMRN)	Outperform -> Outperform	$26.00	Medium
8/13/2019	Svb Leerink	Reiterates	Protagonist Therapeutics (PTGX)	Outperform		Medium
8/13/2019	Svb Leerink	Reiterates	Avedro (AVDR)	Outperform -> Market Perform	$25.00 -> $22.00	High
8/8/2019	Svb Leerink	Reiterates	Inogen (INGN)	Outperform -> Market Perform	$78.00 -> $47.00	High
8/1/2019	Svb Leerink	Reiterates	Teladoc Health (TDOC)	Outperform		Medium
8/5/2019	Svb Leerink	Reiterates	HMS (HMSY)	Outperform -> Outperform	$50.00	Low
7/29/2019	Svb Leerink	Initiates	Kalvista Pharmaceuticals (KALV)	Outperform -> Outperform	$31.00	Low
7/22/2019	Svb Leerink	Initiates	BridgeBio Pharma (BBIO)	Outperform -> Outperform	$34.00	High
7/22/2019	Svb Leerink	Upgrades	Amneal Pharmaceuticals (AMRX)	Market Perform -> Outperform	$11.00 -> $5.00	Low
7/22/2019	Svb Leerink	Initiates	Change Healthcare (CHNG)	Outperform -> Outperform	$20.00	High
7/18/2019	Svb Leerink	Reiterates	Allergan (AGN)	Outperform -> Market Perform	$217.00 -> $188.00	Low
7/15/2019	Svb Leerink	Reiterates	CryoPort (CYRX)	Outperform		Low
7/10/2019	Svb Leerink	Reiterates	Stryker (SYK)	Outperform		Low
7/10/2019	Svb Leerink	Reiterates	Insulet (PODD)	Outperform		Low
7/2/2019	Svb Leerink	Reiterates	PRA Health Sciences (PRAH)	Market Perform		Medium
6/27/2019	Svb Leerink	Downgrades	Aclaris Therapeutics (ACRS)	Outperform -> Market Perform		High
6/26/2019	Svb Leerink	Upgrades	AbbVie (ABBV)	Market Perform -> Outperform	$88.00	High

6/21/2019	Svb Leerink	Initiates	Axovant Gene Therapies (AXGT)	Outperform -> Outperform	$18.00	High
6/20/2019	Svb Leerink	Initiates	Aptinyx (APTX)	Outperform -> Outperform	$12.00	High
6/10/2019	Svb Leerink	Initiates	Charles River Laboratories Intl. (CRL)	Outperform	$155.00	Low
6/5/2019	Svb Leerink	Downgrades	Inflarx (IFRX)	Outperform -> Market Perform		Low
6/3/2019	Svb Leerink	Initiates	Trevi Therapeutics (TRVI)	Outperform -> Outperform	$14.00	High
6/3/2019	Svb Leerink	Initiates	Axcella Health (AXLA)	Outperform -> Outperform	$21.00	Low
5/28/2019	Svb Leerink	Initiates	Alder Biopharmaceuticals (ALDR)	Outperform -> Outperform		High
5/28/2019	Svb Leerink	Initiates	Iqvia (IQV)	Outperform -> Outperform	$160.00	Low
5/22/2019	Svb Leerink	Initiates	Ra Pharmaceuticals (RARX)	Outperform	$33.00	Low
5/15/2019	Svb Leerink	Reiterates	Henry Schein (HSIC)	Outperform -> Market Perform	$75.00 -> $70.00	Low
5/13/2019	Svb Leerink	Initiates	Hookipa Pharma (HOOK)	Outperform	$20.00	Low
5/13/2019	Svb Leerink	Initiates	Turning Point Therapeutics (TPTX)	Outperform -> Outperform	$42.00	High
5/13/2019	Svb Leerink	Initiates	Tandem Diabetes Care (TNDM)	Outperform -> Outperform	$83.00	Low
5/7/2019	Svb Leerink	Downgrades	Intersect ENT (XENT)	Outperform -> Market Perform	$41.00 -> $29.00	High
5/7/2019	Svb Leerink	Reiterates	Adaptimmune Therapeutics (ADAP)	Outperform -> Market Perform	$12.00 -> $5.00	High
5/3/2019	Svb Leerink	Reiterates	Arcus Biosciences (RCUS)	Outperform		High
5/6/2019	Svb Leerink	Initiates	Aclaris Therapeutics (ACRS)	Outperform	$13.00	High
5/3/2019	Svb Leerink	Upgrades	Bruker (BRKR)	Market Perform -> Outperform	$40.00 -> $53.00	High
4/25/2019	Svb Leerink	Upgrades	Nextgen Healthcare (NXGN)	Market Perform -> Outperform	$19.00 -> $22.00	Medium
4/24/2019	Svb Leerink	Initiates	GENFIT S A/ADR (GNFT)	Outperform -> Outperform	$58.00	High
4/23/2019	Svb Leerink	Raises Target	Biohaven Pharmaceutical (BHVN)	Outperform	$50.00 -> $67.00	Medium
4/17/2019	Svb Leerink	Raises Target	Audentes Therapeutics (BOLD)	Outperform	$37.00 -> $48.00	High
4/15/2019	Svb Leerink	Initiates	Tocagen (TOCA)	Mkt Perform -> Market Perform	$11.00	Medium
4/15/2019	Svb Leerink	Reiterates	Aduro BioTech (ADRO)	Outperform -> Outperform	$9.00	High
4/10/2019	Svb Leerink	Downgrades	Premier (PINC)	Outperform -> Market Perform		Low
4/9/2019	Svb Leerink	Lowers Target	Zogenix (ZGNX)	Outperform -> Outperform	$60.00 -> $48.00	Low
4/9/2019	Svb Leerink	Raises Target	Alnylam Pharmaceuticals (ALNY)	Market Perform -> Market Perform	$65.00 -> $70.00	High
4/8/2019	Svb Leerink	Initiates	Axsome Therapeutics (AXSM)	Outperform -> Outperform	$25.00	Medium
3/29/2019	Svb Leerink	Upgrades	Viking Therapeutics (VKTX)	Market Perform -> Outperform	$10.00 -> $21.00	High
3/28/2019	Svb Leerink	Initiates	Fate Therapeutics (FATE)	Outperform	$20.00	Medium
3/28/2019	Svb Leerink	Initiates	Affimed (AFMD)	Outperform	$8.00	High
3/25/2019	Svb Leerink	Reiterates	resTORbio (TORC)	Outperform		Medium
3/20/2019	Svb Leerink	Reiterates	Covetrus (CVET)	Outperform		High
3/19/2019	Svb Leerink	Reiterates	Aurinia Pharmaceuticals (AUP)	Outperform		N/A
3/18/2019	Svb Leerink	Reiterates	Synthorx (THOR)	Outperform		Low
3/19/2019	Svb Leerink	Reiterates	Vertex Pharmaceuticals (VRTX)	Outperform -> Market Perform		High
3/15/2019	Svb Leerink	Initiates	Nektar Therapeutics (NKTR)	Mkt Perform	$38.00	Medium
3/11/2019	Svb Leerink	Downgrades	American Renal Associates (ARA)	Outperform -> Market Perform		High
3/11/2019	Svb Leerink	Initiates	Tcr2 Therapeutics (TCRR)	Outperform	$27.00	High
3/11/2019	Svb Leerink	Initiates	Avedro (AVDR)	Outperform	$20.00	High
3/8/2019	Svb Leerink	Downgrades	Amneal Pharmaceuticals (AMRX)	Outperform -> Market Perform	$16.00 -> $12.00	Low
3/5/2019	Svb Leerink	Reiterates	Sarepta Therapeutics (SRPT)	Outperform		Low
3/5/2019	Svb Leerink	Reiterates	Harpoon Therapeutics (HARP)	Outperform		High
3/5/2019	Svb Leerink	Downgrades	Endo International (ENDP)	Outperform -> Market Perform		Low
3/5/2019	Svb Leerink	Downgrades	bluebird bio (BLUE)	Outperform -> Market Perform		Low
3/5/2019	Svb Leerink	Initiates	Gossamer Bio (GOSS)	Outperform	$30.00	High
3/4/2019	Svb Leerink	Initiates	MannKind (MNKD)	Outperform	$3.00	Medium
3/4/2019	Svb Leerink	Initiates	Alector (ALEC)	Outperform		High
3/4/2019	Svb Leerink	Downgrades	ImmunoGen (IMGN)	Outperform -> Market Perform		High
2/26/2019	Svb Leerink	Reiterates	Retrophin (RTRX)	Outperform		Low

2/21/2019	Svb Leerink	Reiterates	CymaBay Therapeutics (CBAY)	Outperform		Medium
2/25/2019	Svb Leerink	Downgrades	Diplomat Pharmacy (DPLO)	Outperform -> Market Perform	$24.00 -> $6.00	High
2/22/2019	Svb Leerink	Initiates	Viking Therapeutics (VKTX)	Mkt Perform		Low
2/22/2019	Svb Leerink	Initiates	Provention Bio (PRVB)	Outperform	$6.00	Low
2/22/2019	Svb Leerink	Initiates	MannKind (MNKD)	Outperform	$3.00	High
2/22/2019	Svb Leerink	Initiates	Madrigal Pharmaceuticals (MDGL)	Outperform	$165.00	Medium
2/22/2019	Svb Leerink	Initiates	GALAPAGOS NV/S (GLPG)	Outperform		Medium
2/22/2019	Svb Leerink	Reiterates	Equillium (EQ)	Outperform	$16.00	Medium
2/22/2019	Svb Leerink	Initiates	Dermira (DERM)	Outperform	$20.00	High
2/22/2019	Svb Leerink	Downgrades	Intercept Pharmaceuticals (ICPT)	Market Perform -> Underperform	$70.00	Medium
2/15/2019	Svb Leerink	Reiterates	Mirati Therapeutics (MRTX)	Outperform		High
2/14/2019	Svb Leerink	Reiterates	ChemoCentryx (CCXI)	Outperform		N/A
2/15/2019	Svb Leerink	Upgrades	Agios Pharmaceuticals (AGIO)	Market Perform -> Outperform	$80.00	High
2/8/2019	Svb Leerink	Downgrades	Solid Biosciences (SLDB)	Outperform -> Market Perform		Low
2/7/2019	Svb Leerink	Upgrades	Zafgen (ZFGN)	Market Perform -> Outperform		High
2/6/2019	Svb Leerink	Reiterates	Marinus Pharmaceuticals (MRNS)	Outperform		High
1/30/2019	Svb Leerink	Downgrades	Scpharmaceuticals (SCPH)	Outperform -> Market Perform		High

This page was last refreshed on Monday at 06:04 AM ET.

MarketBeat Community Rating for Svb Leerink

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		7,470 (Vote Outperform)
Underperform Votes:		7,915 (Vote Underperform)
Total Votes:		15,385

MarketBeat's community ratings are surveys of what our community members think about Svb Leerink and other research firms. Vote "Outperform" if you believe Svb Leerink's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Svb Leerink's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

See Also:

Svb Leerink Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Svb Leerink

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources